Skip to content
TirzepatideReport
Providers

Tracked provider

Eve tirzepatide review

Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual…

This is a tracked entry: the facts below are what Eve publishes about itself, recorded and re-checked as part of the board we maintain (last checked 2026-06-06). Our hand-written reviews go deeper on the programs people ask about most. Prices change — confirm on Eve's own site before you pay.

What it costs

Tirzepatide
$195/mo (compounded)
What is dispensed
Compounded tirzepatide
Who compounds it
Unspecified

How the program works

An online intake is reviewed by a licensed clinician. Does not publish a price until after the intake.

What we like

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

The caveats

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated

Ready to look at Eve directly? The link below is tracked so we can see it worked; it goes to their own site.

Visit Eve

Advertising disclosure — some, not all, of the providers ranked here are partners, and we may earn a commission at no additional cost to you. The prices and facts we report come from each provider's own published program. Full disclosure.

Other tirzepatide programs we track

← Every provider review